UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000034152
Receipt number R000038931
Scientific Title Evaluation of the effect of L-carnitine administration on survival rates in chronic hemodialysis patients
Date of disclosure of the study information 2018/09/14
Last modified on 2020/03/19 09:20:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the effect of L-carnitine administration on survival rates in chronic hemodialysis patients

Acronym

Effect of L- carnitine administration on survival rates in hemodialysis patients

Scientific Title

Evaluation of the effect of L-carnitine administration on survival rates in chronic hemodialysis patients

Scientific Title:Acronym

Effect of L- carnitine administration on survival rates in hemodialysis patients

Region

Japan


Condition

Condition

Secondary carnitine deficiency

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate the effect of L-carnitine replacement therapy on survival rates in chronic hemodialysis patients with secondary carnitine deficiency

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Improvement of survival rates by administration of L-carnitine

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients over the age of 20 years with end stage renal disease undergoing hemodialysis

Key exclusion criteria

Patients under the age of 20 years old

Patients undergoing combination therapy with peritoneal dialysis and hemodialysis

Others not inadequate judged by a physician

Target sample size

2500


Research contact person

Name of lead principal investigator

1st name Kei
Middle name
Last name Fukami

Organization

Kurume University

Division name

Division of Nephrology, Department on Medicine

Zip code

830-0011

Address

67 Asahi-machi, Kurume-shi, Fukuoka, Japan

TEL

0942-31-7763

Email

fukami@med.kurume-u.ac.jp


Public contact

Name of contact person

1st name Kei
Middle name
Last name Fukami

Organization

Kurume University

Division name

Division of Nephrology, Department on Medicine

Zip code

830-0011

Address

67 Asahi-machi, Kurume-shi, Fukuoka, Japan

TEL

0942-31-7763

Homepage URL


Email

fukami@med.kurume-u.ac.jp


Sponsor or person

Institute

Division of Nephrology, Department on Medicine, Kurume University

Institute

Department

Personal name



Funding Source

Organization

Division of Nephrology, Department on Medicine, Kurume University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kurume University

Address

67 Asahi-machi, Kurume-shi, Fukuoka, Japan

Tel

0942-31-7002

Email

fukami@med.kurume-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

2000

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 09 Month 14 Day

Date of IRB

2016 Year 08 Month 02 Day

Anticipated trial start date

2018 Year 09 Month 14 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Survival rate of chronic hemodialysis patients by administration of L-carnitine


Management information

Registered date

2018 Year 09 Month 14 Day

Last modified on

2020 Year 03 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000038931


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name